Associate professor
Organizational affiliation: Department of Food and Drug
SSD: Technology, Socioeconomics and Regulation of Medicinal and Health and Wellbeing Products (CHEM-08/A)

About

Francesca Buttini is currently holding an Associate Professor position at the Department of Pharmacy, University of Parma (IT) where she got the PhD title in 2004 and where now she is leading the unit dedicated to design of pharmaceutical products for inhalation. In 2014, she was appointed as Visiting Lecturer at the Institute of Pharmaceutical Science of King’s College London (UK). In 2016 she has been affiliated as Key Researcher at the Research Center Pharmaceutical Engineering (Austria). She was awarded as best emerging scientist by aerosol UK society in 2017.

In her career Prof. Buttini put her effort to build a strong expertise in respiratory field and inhalation product keeping the patient needs always in consideration in her research. She works on the development and characterization of innovative pulmonary products such as solutions for nebulisation, metered dose inhalers and dry powder inhalers.

Francesca is a founder of PlumeStars, an innovative SME dedicated to the development of orphan drugs for the treatment of lung diseases through inhalation therapy and is a member of the scientific advisory board of Alveolus Bio, which is developing probiotic products for inhalation.

Curriculum Vitae

Download the CV

Current positions
• Associate Professor, Food and Drug Department, University of Parma (Italy), (SSDcode CHIM / 09 Pharmaceutical Technology) – January 2018 to current;

• Visiting Professor, Institute of Pharmaceutical Science, King’s College London, London, (UK), 2014 to current;

• Affiliated Key Researcher for inhalation Product Design and Development, Research Center Pharmaceutical Engineering GmbH, Graz, (Austria), 2016 to current.

 

Education and Awards

• December 2017, Emerging Scientist Award by the Aerosol Society UK. The award recognises significant scientific accomplishment or innovation during the early stages of an individual's career in inhalation science;

• April 2017, Associate Professor qualification by the National Scientific Italian Committee;

• November 2013 - December 2017, Assistant Professor position (RTDb), Department of Pharmacy of the University of Parma (Italy);

• March 2007, PhD title in Biopharmaceutics Pharmacokinetics (Pharmaceutical Technology Application), research program run at Department of Pharmacy, University of Parma and King’s College London, subject titled "The inhaled administration of dry powder formulations”;

• July 2003, Licensed to practice as a pharmacist at Faculty of Pharmacy of the University of Parma with a score of 227/250;

• April 2003, Degree in Pharmaceutical Science, Faculty of Pharmacy of the University of Parma with full marks and honors, discussion of a thesis entitled "Insulin dry powders for inhalation";

• 2002, Undergraduate Student Award in Pharmaceutical Science, University of Parma.

Teaching

Research

Publications

Research projects

  • Exploring the Future of Inhalation Drug Delivery 2026

    Manager: Buttini Francesca

  • DDL Grant 2023

    Manager: Buttini Francesca

  • “Advanced nasal product characterization: focus deposition and dissolution”

    Manager: Buttini Francesca

Public Engagement Initiatives

  • Open Innovation: strategie e strumenti per innovare collaborando

    Mercoledì 4 novembre 2026 alle ore 15.30 si è tenuto il webinar "Open Innovation: strategie e strumenti per innovare collaborando". In uno scenario economico in continua evoluzione, l’innovazione nasce sempre più dalla capacità delle imprese di aprirsi all’esterno, costruendo solide collaborazioni con università, centri di ricerca e startup. L'incontro, organizzato dalla Camera di commercio dell’Emilia in collaborazione con l’Università di Parma, ha l'obiettivo di offrire alle imprese una panoramica concreta e operativa su queste opportunità. Attraverso gli interventi dei docenti dell'Università di Parma – Prof. Franco Mosconi, Prof. Pierluigi Marchini e Prof.ssa Francesca Buttini – sono stati approfonditi temi cruciali quali: • La creazione di reti territoriali e relazioni strategiche • Le strategie di innovazione aziendale e le esperienze concrete dal mondo industriale • La gestione e tutela della proprietà intellettuale, con un focus specifico su brevetti, titolarità dei risultati e accordi di riservatezza.

  • Articolo "Farmaci da Respirare"

    L’articolo, pubblicato sulla Gazzetta di Parma, illustra in modo divulgativo i principi e i vantaggi della terapia inalatoria, spiegando come i farmaci possano essere somministrati direttamente ai polmoni attraverso dispositivi e formulazioni tecnologicamente avanzati. Un’attenzione particolare è dedicata all’importanza del corretto utilizzo degli inalatori, alle nuove frontiere della ricerca farmaceutica e allo sviluppo di soluzioni innovative e più sostenibili dal punto di vista ambientale, valorizzando anche il contributo della ricerca dell’Università di Parma.

  • Video dedicato a medici pneumologi su "Le conseguenze di un uso improprio dell'inalatore NEXThaler in confronto a Ellipta"

    Video di divulgazione scientifica per personale medico che prescrive medicinali inalatori per asma e bronchite cronica ostruttiva. Video commissionato da Chiesi Farmaceutici destinato al territorio nazionale italiano.

  • Emilia-Romagna Open

    Giornata di porte aperte del Laboratorio della Rete Alta Tecnologia dell'Emilia Romagna Biopharmanet-TEC

  • Notte dei Ricercatori 2019

    Laboratori aperti, esperimenti, mostre, incontri con esperti, spettacoli e molto altro, per mostrare a bambini, giovani e adulti quanto possa essere affascinante e ricca di sfaccettature l’attività di ricerca.

Loading…